Aeropine Eye Drop: Atropine 1% - Potent Cycloplegic and Mydriatic Agent

Mechanism: Anticholinergic Action for Ciliary Muscle Paralysis

Key Indications: Refraction in Children and Therapeutic Use in Severe Uveitis

Preservative Advantage: Stabilized Oxychloro Complex for Enhanced Ocular Comfort

Administration and Important Safety Information (Pupil Dilation and Photophobia)
Exclusive Monopoly: Aeropine Eye Drop PCD Pharma Franchise Opportunity

Home/Products /atropine-sulphate-ip-1-w-v-stabilized-oxychloro-complex-as-preservative-w-v-eye-drop

Aeropine Eye Drop

Composition : Atropine Sulphate IP 1% w/v + Stabilized Oxychloro complex 0.005% w/v

Dosage Form : Eye Drops

Packaging Type : Dropper

Packaging : 5ml

Price : ₹1/-

Aeropine Eye Drop contains Atropine Sulphate 1% w/v, the most powerful anticholinergic agent used in ophthalmology. This concentration is typically reserved for obtaining maximal cycloplegia (paralysis of accommodation) necessary for accurate refractive assessment, particularly in children, and for the strong, sustained mydriasis required in treating severe uveitis (inflammation of the middle layer of the eye).

Mechanism and Impact:Atropine blocks muscarinic receptors, causing both prolonged dilation of the pupil (mydriasis) and complete relaxation of the eye's focusing muscle (cycloplegia). The crucial distinction of this formulation is the inclusion of Stabilized Oxychloro Complex (SOC) 0.005% w/v. SOC is a modern, oxidizing preservative that is less irritating to the ocular surface than traditional agents like Benzalkonium Chloride (BAK) because it rapidly dissipates into water and oxygen upon contact with the eye. This combination delivers clinical potency with improved patient comfort.

Key Therapeutic Uses:

  • Cycloplegic Refraction: The gold standard for determining true refractive error, especially in children with large accommodative power or strabismus.

  • Uveitis/Iritis Treatment: Reduces pain, stabilizes the blood-aqueous barrier, and prevents or breaks down synechiae (adhesions) between the iris and lens.

We offer an exclusive PCD Pharma Franchise opportunity for Aeropine Eye Drop, tapping into the consistent, specialized demand for potent cycloplegic eye drops.

Read More

About the Product

Aeropine Eye Drop contains Atropine Sulphate 1% w/v, the most powerful anticholinergic agent used in ophthalmology. This concentration is typically reserved for obtaining maximal cycloplegia (paralysis of accommodation) necessary for accurate refractive assessment, particularly in children, and for the strong, sustained mydriasis required in treating severe uveitis (inflammation of the middle layer of the eye).

Mechanism and Impact:Atropine blocks muscarinic receptors, causing both prolonged dilation of the pupil (mydriasis) and complete relaxation of the eye's focusing muscle (cycloplegia). The crucial distinction of this formulation is the inclusion of Stabilized Oxychloro Complex (SOC) 0.005% w/v. SOC is a modern, oxidizing preservative that is less irritating to the ocular surface than traditional agents like Benzalkonium Chloride (BAK) because it rapidly dissipates into water and oxygen upon contact with the eye. This combination delivers clinical potency with improved patient comfort.

Key Therapeutic Uses:

  • Cycloplegic Refraction: The gold standard for determining true refractive error, especially in children with large accommodative power or strabismus.

  • Uveitis/Iritis Treatment: Reduces pain, stabilizes the blood-aqueous barrier, and prevents or breaks down synechiae (adhesions) between the iris and lens.

We offer an exclusive PCD Pharma Franchise opportunity for Aeropine Eye Drop, tapping into the consistent, specialized demand for potent cycloplegic eye drops.

Common side effects include frequent urination, dizziness, dehydration, low potassium levels, muscle cramps, weakness, and fatigue. Rare but serious effects may include low blood pressure, kidney dysfunction, or hearing disturbances.

Torslide 5 Tablet is indicated for the management of mild edema due to heart failure, kidney disease, or liver disorders, as well as for controlling mild to moderate hypertension (high blood pressure).

Use this medication only under medical supervision. Regular monitoring of blood pressure, kidney function, and electrolytes is essential. Patients with severe dehydration, kidney impairment, or electrolyte imbalances should consult their doctor before use.

Store in a cool, dry place away from direct sunlight and moisture. Keep out of reach of children and store in its original packaging.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions

What are the business opportunities for Atropine Sulphate IP 1% w/v Stabilized Oxychloro Complex (as preservative) Eye Drops in the PCD pharma franchise market?

This ophthalmic formulation has strong demand in the eye care and hospital segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on ophthalmology and specialty eye-care portfolios.

Why should medical distributors include this eye drop in their product range?

Medical distributors and agencies can benefit from consistent demand for management of eye conditions such as uveitis, myopia control (in selected cases), and diagnostic pupillary dilation procedures. Atropine helps relax eye muscles and is widely used under ophthalmologist supervision, strengthening a reliable ophthalmic product portfolio.

Does Cafoli LifeCare Pvt Ltd offer PCD pharma franchise opportunities for this product?

Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for this ophthalmic eye drop formulation with promotional support, monopoly rights, quality packaging, and competitive pricing for distributors and wholesalers.

What benefits do wholesalers get by partnering for this product?

Wholesalers and medical agencies benefit from steady ophthalmology prescription demand, hospital and clinic usage, specialty eye-care market growth, reliable supply chain support, and good margins when partnering for this ophthalmic product.

How can I become a distributor or franchise partner for this eye drop?

Medical distributors, stockists, and wholesalers interested in this ophthalmic formulation can contact Cafoli LifeCare Pvt Ltd to discuss franchise opportunities, pricing, and distribution support.

Strategic Advisory

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation